Partial  	Partial  	 JJ	B-NP
correction  	correction  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
CNS  	CNS  	 NNP	I-NP
lysosomal  	lysosomal  	 JJ	I-NP
storage  	storage  	 NN	I-NP
defect  	defect  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
mouse  	mouse  	 NN	O
model  	model  	 NN	O
of  	of  	 IN	O
juvenile  	juvenile  	 JJ	O
neuronal  	neuronal  	 JJ	B-NP
ceroid  	ceroid  	 JJ	I-NP
lipofuscinosis  	lipofuscinosis  	 NN	I-NP
by  	by  	 IN	O
neonatal  	neonatal  	 JJ	B-NP
CNS  	CNS  	 NNP	I-NP
administration  	administration  	 NN	I-NP
of  	of  	 IN	O
an  	an  	 DT	O
adeno-associated  	adeno-associated  	 JJ	B-NP
virus  	virus  	 NN	I-NP
serotype  	serotype  	 VBD	O
rh.10  	rh.10  	 CD	B-NP
vector  	vector  	 NN	O
expressing  	expressing  	 VBG	O
the  	the  	 DT	O
human  	human  	 JJ	O
CLN3  	CLN3  	 FW	B-NP
gene  	gene  	 FW	I-NP
Juvenile  	Juvenile  	 FW	I-NP
neuronal  	neuronal  	 FW	I-NP
ceroid  	ceroid  	 FW	I-NP
lipofuscinosis  	lipofuscinosis  	 FW	I-NP
( 	( 	 -LRB-	O
JNCL  	JNCL  	 NNP	B-NP
or  	or  	 CC	O
CLN3  	CLN3  	 CD	O
disease 	disease 	 NN	O
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
an  	an  	 DT	O
autosomal  	autosomal  	 JJ	B-NP
recessive  	recessive  	 JJ	I-NP
lysosomal  	lysosomal  	 JJ	I-NP
storage  	storage  	 NN	I-NP
disease  	disease  	 NN	I-NP
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
CLN3  	CLN3  	 JJ	B-NP
gene  	gene  	 NN	I-NP
that  	that  	 IN	O
encodes  	encodes  	 VBG	O
a  	a  	 DT	O
lysosomal  	lysosomal  	 JJ	B-NP
membrane  	membrane  	 JJ	I-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
disease  	disease  	 NN	O
primarily  	primarily  	 RB	O
affects  	affects  	 VBZ	O
the  	the  	 DT	O
brain  	brain  	 NN	O
with  	with  	 IN	O
widespread  	widespread  	 JJ	O
intralysosomal  	intralysosomal  	 JJ	B-NP
accumulation  	accumulation  	 NN	I-NP
of  	of  	 IN	I-NP
autofluorescent  	autofluorescent  	 JJ	I-NP
material  	material  	 NN	I-NP
and  	and  	 CC	O
fibrillary  	fibrillary  	 JJ	B-NP
gliosis 	gliosis 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
loss  	loss  	 NN	O
of  	of  	 IN	O
specific  	specific  	 JJ	O
neuronal  	neuronal  	 JJ	B-NP
populations 	populations 	 NNS	I-NP
.  	.  	 .	O
As  	As  	 IN	O
an  	an  	 DT	O
experimental  	experimental  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
CNS  	CNS  	 NNP	I-NP
manifestations  	manifestations  	 NNS	I-NP
of  	of  	 IN	I-NP
JNCL 	JNCL 	 NNP	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
have  	have  	 VBP	O
developed  	developed  	 VBN	O
a  	a  	 DT	O
serotype  	serotype  	 JJ	B-NP
rh.10  	rh.10  	 CD	I-NP
adeno-associated  	adeno-associated  	 JJ	O
virus  	virus  	 NN	O
vector  	vector  	 NN	O
expressing  	expressing  	 VBG	O
the  	the  	 DT	O
human  	human  	 JJ	O
CLN3  	CLN3  	 NNP	B-NP
cDNA  	cDNA  	 NNP	I-NP
( 	( 	 -LRB-	O
AAVrh.10hCLN3 	AAVrh.10hCLN3 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
hypothesized  	hypothesized  	 VBD	O
that  	that  	 DT	O
administration  	administration  	 NN	B-NP
of  	of  	 IN	I-NP
AAVrh.10hCLN3  	AAVrh.10hCLN3  	 CD	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
Cln3 	Cln3 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
Δex7 	Δex7 	 CD	I-NP
/ 	/ 	 CD	I-NP
8 	8 	 CD	I-NP
)  	)  	 -RRB-	I-NP
knock-in  	knock-in  	 JJ	O
mouse  	mouse  	 NN	O
model  	model  	 NN	O
of  	of  	 IN	O
JNCL  	JNCL  	 NNP	B-NP
would  	would  	 MD	O
reverse  	reverse  	 VB	O
the  	the  	 DT	O
lysosomal  	lysosomal  	 JJ	B-NP
storage  	storage  	 NN	I-NP
defect 	defect 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 RB	O
have  	have  	 VB	O
a  	a  	 DT	O
therapeutic  	therapeutic  	 JJ	B-NP
effect  	effect  	 NN	I-NP
on  	on  	 IN	O
gliosis  	gliosis  	 NN	B-NP
and  	and  	 CC	O
neuron  	neuron  	 JJ	B-NP
loss 	loss 	 NN	I-NP
.  	.  	 .	O
Newborn  	Newborn  	 NNP	B-NP
Cln3 	Cln3 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
Δex7 	Δex7 	 CD	I-NP
/ 	/ 	 CD	I-NP
8 	8 	 CD	I-NP
)  	)  	 -RRB-	I-NP
mice  	mice  	 NNS	I-NP
were  	were  	 VBD	O
administered  	administered  	 VBN	O
3  	3  	 CD	O
×  	×  	 CD	O
10 	10 	 CD	O
( 	( 	 -LRB-	O
10 	10 	 CD	O
)  	)  	 -RRB-	O
genome  	genome  	 JJ	O
copies  	copies  	 NNS	O
of  	of  	 IN	O
AAVrh.10hCLN3  	AAVrh.10hCLN3  	 CD	B-NP
to  	to  	 TO	O
the  	the  	 DT	O
brain 	brain 	 NN	O
,  	,  	 ,	O
with  	with  	 IN	O
control  	control  	 NN	B-NP
groups  	groups  	 NNS	I-NP
including  	including  	 VBG	O
untreated  	untreated  	 JJ	O
Cln3 	Cln3 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
Δex7 	Δex7 	 CD	I-NP
/ 	/ 	 CD	I-NP
8 	8 	 CD	I-NP
)  	)  	 -RRB-	I-NP
mice  	mice  	 NNS	I-NP
and  	and  	 CC	O
wild-type  	wild-type  	 JJ	B-NP
littermate  	littermate  	 JJ	I-NP
mice 	mice 	 NNS	I-NP
.  	.  	 .	O
After  	After  	 IN	O
18  	18  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
CLN3  	CLN3  	 CD	B-NP
transgene  	transgene  	 JJ	I-NP
expression  	expression  	 NN	I-NP
was  	was  	 VBD	O
detected  	detected  	 VBN	O
in  	in  	 IN	O
various  	various  	 JJ	O
locations  	locations  	 NNS	O
throughout  	throughout  	 IN	O
the  	the  	 DT	O
brain 	brain 	 NN	O
,  	,  	 ,	O
particularly  	particularly  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
hippocampus  	hippocampus  	 NN	B-NP
and  	and  	 CC	O
deep  	deep  	 JJ	O
anterior  	anterior  	 JJ	O
cortical  	cortical  	 JJ	B-NP
regions 	regions 	 NNS	I-NP
.  	.  	 .	O
Changes  	Changes  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
CNS  	CNS  	 NNP	B-NP
neuronal  	neuronal  	 VBD	O
lysosomal  	lysosomal  	 JJ	B-NP
accumulation  	accumulation  	 NN	I-NP
of  	of  	 IN	I-NP
storage  	storage  	 NN	I-NP
material  	material  	 NN	I-NP
were  	were  	 VBD	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
immunodetection  	immunodetection  	 NN	B-NP
of  	of  	 IN	O
subunit  	subunit  	 JJ	O
C  	C  	 NNP	O
of  	of  	 IN	O
ATP  	ATP  	 NNP	B-NP
synthase 	synthase 	 NN	I-NP
,  	,  	 ,	O
luxol  	luxol  	 VBD	O
fast  	fast  	 RB	O
blue  	blue  	 JJ	O
staining 	staining 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
periodic  	periodic  	 JJ	B-NP
acid-Schiff  	acid-Schiff  	 JJ	I-NP
staining 	staining 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
all  	all  	 DT	O
parameters 	parameters 	 NN	O
,  	,  	 ,	O
Cln3 	Cln3 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
Δex7 	Δex7 	 CD	I-NP
/ 	/ 	 CD	I-NP
8 	8 	 CD	I-NP
)  	)  	 -RRB-	I-NP
mice  	mice  	 FW	I-NP
exhibited  	exhibited  	 FW	O
abnormal  	abnormal  	 FW	O
lysosomal  	lysosomal  	 FW	B-NP
accumulation 	accumulation 	 FW	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
AAVrh.10hCLN3  	AAVrh.10hCLN3  	 CD	B-NP
administration  	administration  	 NN	O
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
significant  	significant  	 JJ	O
reductions  	reductions  	 NNS	O
in  	in  	 IN	O
storage  	storage  	 NN	B-NP
material  	material  	 NN	I-NP
burden 	burden 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
also  	also  	 RB	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
gliosis  	gliosis  	 NN	B-NP
in  	in  	 IN	O
AAVrh.10hCLN3-treated  	AAVrh.10hCLN3-treated  	 NNP	B-NP
Cln3 	Cln3 	 NNP	O
( 	( 	 -LRB-	O
Δex7 	Δex7 	 CD	O
/ 	/ 	 CD	O
8 	8 	 CD	O
)  	)  	 -RRB-	O
mice 	mice 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
trend  	trend  	 NN	O
toward  	toward  	 IN	O
improved  	improved  	 JJ	O
neuron  	neuron  	 JJ	B-NP
counts 	counts 	 NNS	I-NP
,  	,  	 ,	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
their  	their  	 PRP$	O
untreated  	untreated  	 JJ	O
counterparts 	counterparts 	 NNS	B-NP
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
demonstrate  	demonstrate  	 VBP	O
that  	that  	 IN	O
AAVrh.10  	AAVrh.10  	 CD	B-NP
delivery  	delivery  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
wild-type  	wild-type  	 JJ	B-NP
cDNA  	cDNA  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
CNS  	CNS  	 NNP	B-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
harmful  	harmful  	 JJ	O
and  	and  	 CC	O
instead  	instead  	 RB	O
provides  	provides  	 VBZ	O
a  	a  	 DT	O
partial  	partial  	 JJ	O
correction  	correction  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
neurological  	neurological  	 JJ	B-NP
lysosomal  	lysosomal  	 JJ	I-NP
storage  	storage  	 NN	I-NP
defect  	defect  	 NN	I-NP
of  	of  	 IN	O
a  	a  	 DT	O
disease  	disease  	 NN	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
lysosomal  	lysosomal  	 JJ	B-NP
membrane  	membrane  	 JJ	I-NP
protein 	protein 	 NN	I-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
that  	that  	 IN	O
this  	this  	 DT	O
may  	may  	 MD	O
be  	be  	 VB	O
an  	an  	 DT	O
effective  	effective  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
strategy  	strategy  	 NN	I-NP
for  	for  	 IN	I-NP
JNCL  	JNCL  	 NNP	I-NP
and  	and  	 CC	O
other  	other  	 JJ	O
diseases  	diseases  	 NNS	O
in  	in  	 IN	O
this  	this  	 DT	O
category 	category 	 NN	O
.  	.  	 .	O
